Actively Recruiting
Observational Study on Relapse and Quality of Life in Patients Undergoing Nephroureterectomy Surgery for Upper Urinary Tract Urothelial Carcinoma
Led by IRCCS San Raffaele · Updated on 2023-12-13
1250
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research focuses on patients diagnosed with upper urinary tract urothelial carcinoma who have undergone nephroureterectomy surgery. It aims to observe the occurrence of cancer relapses and assess patients' quality of life, including oncological, psychological, and sexual aspects. The study is both prospective and retrospective, collecting data from patients treated since 1987 to improve clinical understanding and patient care. The study involves collecting detailed information about the patients' pathological status and quality of life through a specially created secure database. Retrospective data from hospital archives will be used alongside new data from ongoing patients. No experimental treatments are administered, as this is an observational study monitoring outcomes after nephroureterectomy surgery. Participants will be monitored over a long period, with clinical progression data collected for up to 50 years. Researchers will gather oncological relapse information, clinical progression, and quality of life data through clinical reports and patient records. This helps develop better therapeutic strategies and support for patients with this type of cancer.
CONDITIONS
Brief Title
Translational Cancer Observational Protocol
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Diagnosed with upper tract urothelial cancer
- Recommended for cancer removal through nephroureterectomy surgery
- Able to read and sign the informed consent
You will not qualify if you...
- Under 18 years of age
- No diagnosis of upper tract urothelial cancer
- Unable to read or sign the informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 to 2 weeks
Participants undergo nephroureterectomy surgery for cancer removal and receive immediate post-operative care.
1 hospital stay for surgery and immediate recovery
Duration - Up to 50 years
Participants are observed over a long period to monitor oncological relapse, clinical progression, and quality of life after surgery.
Periodic visits depending on clinical follow-up schedule
Trial Site Locations
Total: 1 location
1
IRCCS Ospedale San Raffaele
Milan, MI, Italy, 20132
Actively Recruiting
Research Team
F
Francesco Montorsi, MD.
F
Francesco Fiorio, MSC
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here